Skip to Main Content

Author Details

Marco Vignuzzi
Quantitative Biosciences Institute (QBI) Coronavirus Research Group (QCRG)
2001
115
44
Trey Ideker (CM4AI)
PMIDPaper TitleJournal TitlePublished Year
36700640Virology under the Microscope-a Call for Rational Discourse.J Virol2023
37758692Proteomic and genetic analyses of influenza A viruses identify pan-viral host targets.Nat Commun2023
37550340A conformational rearrangement of the SARS-CoV-2 host protein sigma-1 is required for antiviral activity: insights from a combined in-silico/in-vitro approach.Sci Rep2023
37018377The E2 glycoprotein holds key residues for Mayaro virus adaptation to the urban Aedes aegypti mosquito.PLoS Pathog2023
36700653Virology under the Microscope-a Call for Rational Discourse.mSphere2023
36700642Virology under the Microscope-a Call for Rational Discourse.mBio2023
34705560Chemical Evolution of Rhinovirus Identifies Capsid-Destabilizing Mutations Driving Low-pH-Independent Genome Uncoating.J Virol2022
35468712Packaging, Purification, and Titration of Replication-Deficient Semliki Forest Virus-Derived Particles as a Self-Amplifying mRNA Vaccine VectorIran Biomed J2022
35762523Interactions between vector competence to chikungunya virus and resistance to deltamethrin in Aedes aegypti laboratory lines?Med Vet Entomol2022
35360100Exploring Zebrafish Larvae as a COVID-19 Model: Probable Abortive SARS-CoV-2 Replication in the Swim Bladder.Front Cell Infect Microbiol2022
34914162A virus-derived microRNA targets immune response genes during SARS-CoV-2 infection.EMBO Rep2022
35027731BRD2 inhibition blocks SARS-CoV-2 infection by reducing transcription of the host cell receptor ACE2.Nat Cell Biol2022
35301120An alphavirus-derived self-amplifying mRNA encoding PpSP15-LmSTI1 fusion protein for the design of a vaccine against leishmaniasis.Parasitol Int2022
35022749APOBEC3C S188I Polymorphism Enhances Context-Specific Editing of Hepatitis B Virus Genome.J Infect Dis2022
34086776Comparative analysis of neuroinvasion by Japanese encephalitis virulent and vaccine viral strains in an in vitro model of human blood-brain barrier.PLoS One2021
33495306Plitidepsin has potent preclinical efficacy against SARS-CoV-2 by targeting the host protein eEF1A.Science2021
33791693Phospholipidosis is a shared mechanism underlying the in vitro antiviral activity of many repurposed drugs against SARS-CoV-2.bioRxiv2021
33846459Sustained high expression of multiple APOBEC3 cytidine deaminases in systemic lupus erythematosus.Sci Rep2021
33864728Host PDZ-containing proteins targeted by SARS-CoV-2.FEBS J2021
33863888Defective viral genomes as therapeutic interfering particles against flavivirus infection in mammalian and mosquito hosts.Nat Commun2021
33556143Defective viral genomes from chikungunya virus are broad-spectrum antivirals and prevent virus dissemination in mosquitoes.PLoS Pathog2021
33501440BRD2 inhibition blocks SARS-CoV-2 infection by reducing transcription of the host cell receptor ACE2.bioRxiv2021
33496226Vaccine-Derived Polioviruses, Central African Republic, 2019.Emerg Infect Dis2021
34499915Mathematical modelling of SARS-CoV-2 infection of human and animal host cells reveals differences in the infection rates and delays in viral particle production by infected cells.J Theor Biol2021
34468320A cold case: non-replicative recombination in positive-strand RNA viruses.Virologie (Montrouge)2021
34468319[A cold case: non-replicative recombination in positive-strand RNA viruses].Virologie (Montrouge)2021
34468175Intra- and Inter-cellular Modeling of Dynamic Interaction between Zika Virus and Its Naturally Occurring Defective Viral Genomes.J Virol2021
34548480Characterising proteolysis during SARS-CoV-2 infection identifies viral cleavage sites and cellular targets with therapeutic potential.Nat Commun2021
34809467Herpes Simplex Virus Type 1 Infection Disturbs the Mitochondrial Network, Leading to Type I Interferon Production through the RNA Polymerase III/RIG-I Pathway.mBio2021
34687604Induced intra- and intermolecular template switching as a therapeutic mechanism against RNA viruses.Mol Cell2021
34326236Drug-induced phospholipidosis confounds drug repurposing for SARS-CoV-2.Science2021
34214632Quantitative evaluation of PpSP15-LmSTI1 fusion gene expression following transfection with an alphavirus-derived self-amplifying mRNA and conventional DNA vaccine platforms.Mol Cell Probes2021
34285133Masitinib is a broad coronavirus 3CL inhibitor that blocks replication of SARS-CoV-2.Science2021
32429277Modelling Degradation and Replication Kinetics of the Zika Virus In Vitro Infection.Viruses2020
32102877High-Throughput Fluorescence-Based Screen Identifies the Neuronal MicroRNA miR-124 as a Positive Regulator of Alphavirus Infection.J Virol2020
33060197Comparative host-coronavirus protein interaction networks reveal pan-viral disease mechanisms.Science2020
33154106An ultrapotent synthetic nanobody neutralizes SARS-CoV-2 by stabilizing inactive Spike.Science2020
33180795Chikungunya virus superinfection exclusion is mediated by a block in viral replication and does not rely on non-structural protein 2.PLoS One2020
32929001RNA-seq accuracy and reproducibility for the mapping and quantification of influenza defective viral genomes.RNA2020
32817938An ultra-potent synthetic nanobody neutralizes SARS-CoV-2 by locking Spike into an inactive conformation.bioRxiv2020
32645325The Global Phosphorylation Landscape of SARS-CoV-2 Infection.Cell2020
32353859A SARS-CoV-2 protein interaction map reveals targets for drug repurposing.Nature2020
30346482Long-term context-dependent genetic adaptation of the viral genetic cloud.Bioinformatics2019
31710653Host nutritional status affects alphavirus virulence, transmission, and evolution.PLoS Pathog2019
31270226Chikungunya Virus Vaccine Candidates with Decreased Mutational Robustness Are Attenuated <i>In Vivo</i> and Have Compromised Transmissibility.J Virol2019
31483603Correction to Cell-Based High-Throughput Screening Assay Identifies 2',2'-Difluoro-2'-deoxycytidine Gemcitabine as a Potential Antipoliovirus Agent.ACS Infect Dis2019
31336826Usutu Virus: An Arbovirus on the Rise.Viruses2019
31392032DISSEQT-DIStribution-based modeling of SEQuence space Time dynamics.Virus Evol2019
31091828Arthritogenic Alphaviruses: A Worldwide Emerging Threat?Microorganisms2019
31160826Defective viral genomes are key drivers of the virus-host interaction.Nat Microbiol2019
  • 1 - 50 of 115

Recommended Authors

Aminu S Jahun
University of Cambridge, Addenbrooke's Hospital Level 5
Career Start Year 2017
Number of shared co-authors 20
Yushen Du
University of California los angeles
Career Start Year 2014
Number of shared co-authors 6
Anderson F Brito
Yale School of Medicine, USA Instituto Todos pela Saude
Career Start Year 2013
Number of shared co-authors 2
David Sachs
Icahn School of Medicine at Mount Sinai
Career Start Year 2013
Number of shared co-authors 15
Nathan D Grubaugh
Yale School of Public Health
Career Start Year 2013
Number of shared co-authors 4
Hongjie Xia
University of Texas Medical Branch
Career Start Year 2012
Number of shared co-authors 1
Chao Shan
Wuhan Institute of Virology, Chinese Academy of Sciences
Career Start Year 2012
Number of shared co-authors 2
Xuping Xie
University of Texas Medical Branch
Career Start Year 2010
Number of shared co-authors 8
Brett E Pickett
Brigham Young University
Career Start Year 2009
Number of shared co-authors 4
Kenneth S Plante
University of Texas Medical Branch
Career Start Year 2009
Number of shared co-authors 3
Clayton R Morrison
University of North Carolina School of Medicine
Career Start Year 2008
Number of shared co-authors 3
Hans-Heinrich Hoffmann
The Rockefeller University
Career Start Year 2008
Number of shared co-authors 7
Alexander N Freiberg
University of Texas Medical Branch
Career Start Year 2008
Number of shared co-authors 6
Shannan L Rossi
Institute for Human Infection and Immunity, University of Texas Medical Branch
Career Start Year 2005
Number of shared co-authors 1
Pavitra Roychoudhury
Fred Hutchinson Cancer Center
Career Start Year 2004
Number of shared co-authors 2
Rachel L Graham
University of North Carolina
Career Start Year 2004
Number of shared co-authors 2
Priya S Shah
University of California davis
Career Start Year 2002
Number of shared co-authors 18
Luis Martinez-Sobrido
Texas Biomedical Research Institute
Career Start Year 2001
Number of shared co-authors 48
Jens H Kuhn
National Institute of Allergy and Infectious Diseases, National Institutes of Health
Career Start Year 1998
Number of shared co-authors 8
Elodie Ghedin
National Institute of Allergy and Infectious Diseases, National Institutes of Health
Career Start Year 1996
Number of shared co-authors 11
Ian Goodfellow
University of Cambridge
Career Start Year 1996
Number of shared co-authors 25
Pei-Yong Shi
University of Texas Medical Branch
Career Start Year 1996
Number of shared co-authors 11
Philippe Le Mercier
carnegie mellon university
Career Start Year 1996
Number of shared co-authors 3
Boyd L Yount
University of North Carolina at Chapel Hill
Career Start Year 1993
Number of shared co-authors 7
Gabriele Neumann
Influenza Research Institute, University of Wisconsin-Madison
Career Start Year 1993
Number of shared co-authors 7
Lucy Thorne
University College London
Career Start Year 1992
Number of shared co-authors 23
Andrea V Gamarnik
Fundacion Instituto Leloir-CONICET
Career Start Year 1991
Number of shared co-authors 12
Martin Schwemmle
Institute of Virology, Medical Center - University of Freiburg
Career Start Year 1989
Number of shared co-authors 15
Steven G Widen
University of Texas Medical Branch
Career Start Year 1983
Number of shared co-authors 6
Ralph S Baric
University of North Carolina
Career Start Year 1981
Number of shared co-authors 13

Collaborators

Thomas Vallet
Institut Pasteur, Center for the Viral Populations and Pathogenesis
Co-authored papers 22
Veronica V Rezelj
Quantitative Biosciences Institute (QBI) Coronavirus Research Group (QCRG)
Co-authored papers 21
Adolfo Garc??a-Sastre
Icahn School of Medicine at Mount Sinai
Co-authored papers 11
Raul Andino
University of California san francisco
Co-authored papers 10
Nevan J Krogan (CM4AI)
University of California San Francisco
Co-authored papers 9
Kris M White
Quantitative Biosciences Institute (QBI) Coronavirus Research Group (QCRG)
Co-authored papers 9
Kevan M Shokat
University of California San Francisco
Co-authored papers 7
Benjamin R tenOever
NYU Grossman School of Medicine
Co-authored papers 7
Brian K Shoichet
Department of Pharmaceutical Chemistry, University of California san francisco
Co-authored papers 6
Danielle L Swaney
J. David Gladstone Institutes
Co-authored papers 6
Tia A Tummino
Quantitative Biosciences Institute (QBI), University of California San Francisco
Co-authored papers 5
Melanie Ott
Gladstone Institute of Virology
Co-authored papers 5
Mehdi Bouhaddou
J. David Gladstone Institutes
Co-authored papers 5
Bjoern Meyer
Institut Pasteur
Co-authored papers 5
Jyoti Batra
J. David Gladstone Institutes
Co-authored papers 5
Djoshkun Shengjuler
Institut Pasteur
Co-authored papers 4
Olivier Schwartz
Institut Pasteur, Universite Paris Cite, CNRS UMR9
Co-authored papers 4
Matthew J O'Meara
University of Michigan ann arbor
Co-authored papers 4
Matthew B Frieman
Center for Pathogen Research, University of Maryland School of Medicine
Co-authored papers 4
Cassandra Koh
Institut Pasteur, Universite Paris Cite, CNRS UMR3569
Co-authored papers 4
Lisa Miorin
Icahn School of Medicine at Mount Sinai
Co-authored papers 4
Margaret Soucheray
J. David Gladstone Institutes
Co-authored papers 4
Kirsten Obernier (CM4AI)
University of California San Francisco
Co-authored papers 4
Raphael Trenker
Cardiovascular Research Institute, University of California San Francisco
Co-authored papers 4
Mark R Denison
Vanderbilt University Medical Center
Co-authored papers 4
Michael Emerman
Fred Hutchinson Cancer Center
Co-authored papers 4
Jared Carlson-Stevermer
Synthego Corporation
Co-authored papers 4
Nastaran Sadat Savar
Pasteur Institute of Iran
Co-authored papers 4
Robyn M Kaake
J. David Gladstone Institutes
Co-authored papers 4
Nicholas S Heaton
Duke University School of Medicine
Co-authored papers 4
Release 1.2